Brazilian consensus on non-cystic fibrosis bronchiectasis

Author:

Pereira Mônica Corso1ORCID,Athanazio Rodrigo Abensur2ORCID,Dalcin Paulo de Tarso Roth3ORCID,Figueiredo Mara Rúbia Fernandes de4ORCID,Gomes Mauro5ORCID,Freitas Clarice Guimarães de6ORCID,Ludgren Fernando7ORCID,Paschoal Ilma Aparecida1ORCID,Rached Samia Zahi2ORCID,Maurici Rosemeri8ORCID

Affiliation:

1. Universidade Estadual de Campinas, Brazil

2. Universidade de São Paulo, Brazil

3. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brasil

4. Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Brasil

5. Santa Casa de São Paulo, Brazil; Hospital Samaritano, Brazil

6. Instituto Hospital de Base do Distrito Federal, Brasil

7. Hospital Otavio de Freitas, Brasil

8. Universidade Federal de Santa Catarina, Brazil

Abstract

ABSTRACT Bronchiectasis is a condition that has been increasingly diagnosed by chest HRCT. In the literature, bronchiectasis is divided into bronchiectasis secondary to cystic fibrosis and bronchiectasis not associated with cystic fibrosis, which is termed non-cystic fibrosis bronchiectasis. Many causes can lead to the development of bronchiectasis, and patients usually have chronic airway symptoms, recurrent infections, and CT abnormalities consistent with the condition. The first international guideline on the diagnosis and treatment of non-cystic fibrosis bronchiectasis was published in 2010. In Brazil, this is the first review document aimed at systematizing the knowledge that has been accumulated on the subject to date. Because there is insufficient evidence on which to base recommendations for various treatment topics, here the decision was made to prepare an expert consensus document. The Brazilian Thoracic Association Committee on Respiratory Infections summoned 10 pulmonologists with expertise in bronchiectasis in Brazil to conduct a critical assessment of the available scientific evidence and international guidelines, as well as to identify aspects that are relevant to the understanding of the heterogeneity of bronchiectasis and to its diagnostic and therapeutic management. Five broad topics were established (pathophysiology, diagnosis, monitoring of stable patients, treatment of stable patients, and management of exacerbations). After this subdivision, the topics were distributed among the authors, who conducted a nonsystematic review of the literature, giving priority to major publications in the specific areas, including original articles, review articles, and systematic reviews. The authors reviewed and commented on all topics, producing a single final document that was approved by consensus.

Publisher

FapUNIFESP (SciELO)

Subject

Pulmonary and Respiratory Medicine

Reference164 articles.

1. Bronchiectasis update of an orphan disease;Barker AF;Am Rev Respir Dis,1988

2. Perfil da morbimortalidade por doenças respirato´rias crônicas no Brasil, 2003 a 2013,2016

3. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis;Chandrasekaran R;BMC Pulm Med,2018

4. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007;Seitz AE;Chest,2012

5. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013;Weycker D;Chron Respir Dis,2017

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3